Minerva Neurosciences Statistics
Total Valuation
NERV has a market cap or net worth of $105.65 million. The enterprise value is $88.71 million.
Important Dates
The last earnings date was Friday, November 6, 2026, before market open.
| Earnings Date | Nov 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NERV has 49.84 million shares outstanding. The number of shares has increased by 398.74% in one year.
| Current Share Class | 49.84M |
| Shares Outstanding | 49.84M |
| Shares Change (YoY) | +398.74% |
| Shares Change (QoQ) | -4.87% |
| Owned by Insiders (%) | 0.61% |
| Owned by Institutions (%) | 67.02% |
| Float | 36.39M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 33.02
| Current Ratio | 33.02 |
| Quick Ratio | 30.46 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -34.75% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -36.69% |
| Weighted Average Cost of Capital (WACC) | 2.75% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$41.55M |
| Employee Count | 7 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -50.70% in the last 52 weeks. The beta is 0.01, so NERV's price volatility has been lower than the market average.
| Beta (5Y) | 0.01 |
| 52-Week Price Change | -50.70% |
| 50-Day Moving Average | 2.84 |
| 200-Day Moving Average | 4.76 |
| Relative Strength Index (RSI) | 36.10 |
| Average Volume (20 Days) | 203,044 |
Short Selling Information
The latest short interest is 1.90 million, so 3.81% of the outstanding shares have been sold short.
| Short Interest | 1.90M |
| Short Previous Month | 2.41M |
| Short % of Shares Out | 3.81% |
| Short % of Float | 5.21% |
| Short Ratio (days to cover) | 12.23 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -35.13M |
| Pretax Income | -290.86M |
| Net Income | -290.86M |
| EBITDA | -35.12M |
| EBIT | -35.13M |
| Earnings Per Share (EPS) | -$8.44 |
Full Income Statement Balance Sheet
The company has $76.94 million in cash and $60.00 million in debt, with a net cash position of $16.94 million or $0.34 per share.
| Cash & Cash Equivalents | 76.94M |
| Total Debt | 60.00M |
| Net Cash | 16.94M |
| Net Cash Per Share | $0.34 |
| Equity (Book Value) | -85.78M |
| Book Value Per Share | -1.96 |
| Working Capital | 80.88M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -31.40M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 5,442 |
| Net Borrowing | n/a |
| Free Cash Flow | -31.40M |
| FCF Per Share | -$0.63 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NERV does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -398.74% |
| Shareholder Yield | -398.74% |
| Earnings Yield | -398.17% |
| FCF Yield | -30.01% |
Analyst Forecast
The average price target for NERV is $10.33, which is 387.26% higher than the current price. The consensus rating is "Buy".
| Price Target | $10.33 |
| Price Target Difference | 387.26% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on June 21, 2022. It was a reverse split with a ratio of 1:8.
| Last Split Date | Jun 21, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:8 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |